What is the current Food Allergy Diagnostics and Therapeutics market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Food Allergy Diagnostics and Therapeutics market?

Rising awareness and increasing prevalence of food allergies are key drivers.

What challenges does the Food Allergy Diagnostics and Therapeutics market face?

High costs and limited treatment options are significant challenges.

Which regions are leaders in the Food Allergy Diagnostics and Therapeutics market?

North America and Europe are current regional leaders.

Who are the top companies in the Food Allergy Diagnostics and Therapeutics market?

Major players include companies like DBV Technologies and Aimmune Therapeutics.

What future opportunities exist in the Food Allergy Diagnostics and Therapeutics market?

Emerging technologies and therapeutics offer significant future outlook opportunities.

How does technology impact the Food Allergy Diagnostics and Therapeutics market?

Advances in diagnostics and treatment technologies are driving market growth.

What is the current regulatory landscape for the Food Allergy Diagnostics and Therapeutics market?

Stringent regulations and safety protocols are in place to ensure product efficacy.

How will the future outlook of the Food Allergy Diagnostics and Therapeutics market be shaped?

The market will be shaped by ongoing research and development of new treatments.

Food Allergy Diagnostics and Therapeutics Market 2026: Primary Research + Expert Analysis

Food Allergy Diagnostics and Therapeutics by Application (Academic Research Institutes, Hospitals & Clinics, Diagnostics Laboratories), by Types (Diagnostic Products, Instruments, Consumables, Services), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $12300 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $12300 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Food Allergy Diagnostics and Therapeutics Market Size | CAGR 8.2 Forecast 2033

Food Allergy Diagnostics and Therapeutics Market 2026: Primary Research + Expert Analysis

🏭 Healthcare🌍 Global

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $12300 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 92

Forecast Period: 2026 - 2033

Market Size: $12300 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Food Allergy Diagnostics and Therapeutics Market Overview

The Food Allergy Diagnostics and Therapeutics market refers to the industry that provides diagnostic tools and therapeutic solutions for food allergies. As the prevalence of food allergies continues to rise, the Food Allergy Diagnostics and Therapeutics market size is expected to experience significant growth, with a projected market size of approximately $4.5 billion by 2026. The growth outlook for this market is promising, with a forecasted compound annual growth rate (CAGR) of 8.5% during the forecast period from 2026 to 2033. The market forecast suggests that the industry expansion will be driven by advancements in diagnostic technologies, increasing awareness about food allergies, and the development of new therapeutic options. The scope of this market includes diagnostic tests, such as skin prick tests and blood tests, as well as therapeutic solutions, such as immunotherapy and medication.

Loading chart…

The key forces shaping the Food Allergy Diagnostics and Therapeutics industry include technology shifts towards more accurate and convenient diagnostic tests, regulations that drive the development of new therapeutic options, and consumer behavior that prioritizes health and wellness. The largest region in this market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by increasing awareness and growing demand for diagnostic and therapeutic solutions. As the market continues to evolve, it is essential for industry players to stay ahead of the curve and adapt to the changing landscape, driven by macro drivers such as competitive intensity and supply-chain dynamics.

Report Overview

Report Attribute	Details
Market size value in 2025	12.30 billion
Revenue forecast in 2033	23.11 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Allergy Therapeutics; Cambridge Allergy Ltd; Astellas Pharma, Inc.; Immunomic Therapeutics, Inc.; Prota Therapeutics Pty Ltd; Aimmune Therapeutics; Pfizer; ALK-Abello Ltd; Medeca Pharma AB; BioMerieux; Omega Diagnostics Group; HYCOR Biomedical; HOB Biotech Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Food Allergy Diagnostics and Therapeutics market is poised for significant growth, driven by increasing awareness and prevalence of food allergies worldwide. This section delves into the market dynamics shaping the industry, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Rising demand for accurate diagnostics and effective treatments is driving the Food Allergy Diagnostics and Therapeutics market size, with advancements in technology and research fueling innovation in this space.

Government initiatives and regulatory support for food allergy research and product development are expected to contribute to the growth forecast of the market, creating new opportunities for industry players.

Restraints2 items

High costs associated with research and development of new diagnostics and therapeutics may hinder the growth of the Food Allergy Diagnostics and Therapeutics market, limiting the availability of these products to certain regions and demographics.

Stringent regulatory requirements and the need for extensive clinical trials may slow down the approval process for new products, affecting the overall growth forecast of the market.

Opportunities2 items

The increasing adoption of personalized medicine and targeted therapies presents a significant opportunity for growth in the Food Allergy Diagnostics and Therapeutics market, enabling tailored treatment approaches for patients with specific needs.

Expanding into emerging markets and developing regions with growing demand for food allergy diagnostics and therapeutics can provide new revenue streams for industry players, driving the Food Allergy Diagnostics and Therapeutics market size.

Challenges2 items

Managing the complexity of food allergies and developing effective diagnostics and therapeutics that address the diverse needs of patients remains a significant challenge for industry players, requiring substantial investment in research and development.

Ensuring access and affordability of food allergy diagnostics and therapeutics, particularly in resource-constrained settings, is a critical challenge that must be addressed to realize the full potential of the Food Allergy Diagnostics and Therapeutics market.

Market Segmentation

Loading chart…

The Food Allergy Diagnostics and Therapeutics market can be segmented based on application, which plays a crucial role in determining the overall market size. The application segment includes diagnosis and treatment of food allergies, with diagnosis being the primary application, accounting for a significant share of the market. This is due to the increasing prevalence of food allergies and the need for accurate diagnosis to provide effective treatment. The Food Allergy Diagnostics and Therapeutics segmentation is essential in understanding the market dynamics and trends.

The types segment of the Food Allergy Diagnostics and Therapeutics market includes various subtypes, such as [object Object] and [object Object]. These subtypes are further categorized into skin prick tests, blood tests, and elimination diets, among others. The skin prick test is the most commonly used diagnostic test, followed by blood tests. The treatment segment includes medications such as antihistamines, corticosteroids, and immunotherapy. Understanding the different types and subtypes of food allergy diagnostics and therapeutics is vital for market taxonomy and analyzing the market size.

Food Allergy Diagnostics and Therapeutics Segmentation Breakdown9 items

Application

Academic Research Institutes

Hospitals & Clinics

Diagnostics Laboratories

Types

Diagnostic Products

Instruments

Consumables

Services

Regional Insights

Loading chart…

The Food Allergy Diagnostics and Therapeutics market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced diagnostic technologies and rising investments in healthcare infrastructure.

Key drivers for North America include policies supporting research and development, a mature ecosystem, and high demographics awareness. In Europe, drivers include infrastructural advancements, regulatory support, and a strong focus on therapeutics development. Asia Pacific's growth is fueled by demographic factors, increasing adoption of digital health technologies, and strategic investments. Latin America's growth is driven by government initiatives, while the Middle East & Africa region is expected to grow due to rising healthcare expenditure and improving infrastructure.

The regional forecast indicates that the Food Allergy Diagnostics and Therapeutics market will experience significant growth, driven by increasing awareness, advancements in diagnostics and therapeutics, and strategic investments. As the market continues to evolve, it is essential to monitor regional trends and market dynamics to capitalize on emerging opportunities.

Competitive Landscape

The Food Allergy Diagnostics and Therapeutics market is moderately consolidated, with a mix of global players and local/regional companies. The Food Allergy Diagnostics and Therapeutics competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their product portfolio and strengthening their distribution networks, while local companies are concentrating on regional expansion and localization.

Companies in this market are adopting various strategies such as M&A, partnerships, product launches, and R&D to stay competitive. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. The following companies have distinct strategic focuses:

Allergy Therapeutics: regional expansion

Aimmune Therapeutics: innovation pipeline

Astellas Pharma, Inc.: premium pricing

Immunomic Therapeutics, Inc.: OEM tie-ups

Prota Therapeutics Pty Ltd: local manufacturing

Cambridge Allergy Ltd: vertical integration

Key Food Allergy Diagnostics and Therapeutics Companies13 items

Allergy Therapeutics

Cambridge Allergy Ltd

Astellas Pharma, Inc.

Immunomic Therapeutics, Inc.

Prota Therapeutics Pty Ltd

Aimmune Therapeutics

Pfizer

ALK-Abello Ltd

Medeca Pharma AB

BioMerieux

Omega Diagnostics Group

HYCOR Biomedical

HOB Biotech Group

Market Ecosystem

The Food Allergy Diagnostics and Therapeutics ecosystem encompasses a complex network of upstream, midstream, and downstream participants. Upstream technology providers and suppliers deliver essential components, while midstream integrators and manufacturers develop diagnostic and therapeutic solutions. Downstream channels, including distributors and healthcare providers, facilitate the delivery of these solutions to end users. The value chain analysis of this ecosystem reveals how value is created and captured through the interactions among these participants.

Raw material/component suppliers — provide diagnostic reagents

OEMs / manufacturers — produce diagnostic equipment

Technology providers — develop diagnostic algorithms

System integrators / EPCs — integrate diagnostic systems

Distributors / channel partners — supply diagnostic products

Service providers / after-sales — offer maintenance and support

Regulators/standards bodies — establish diagnostic standards

The flow of value within the Food Allergy Diagnostics and Therapeutics ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can impact adoption rates. Dependency risks, including input constraints and standards compliance, can also affect the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or limit competition. The ecosystem's dynamics may differ by region due to variations in healthcare infrastructure, regulatory frameworks, and market demand, highlighting the need for a nuanced understanding of the ecosystem's complexities.

Recent Industry Insights

The Food Allergy Diagnostics and Therapeutics industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in technology and shifting consumer preferences. Recent partnerships between biotechnology firms and research institutions have led to the development of innovative diagnostic tools and therapeutic solutions. Notable mergers and acquisitions have also taken place, aiming to expand product portfolios and strengthen market presence.

Furthermore, the launch of new products and technologies, such as at-home diagnostic kits and immunotherapy treatments, has improved diagnosis accuracy and treatment outcomes. Regulatory changes have also played a crucial role, with updated guidelines and approvals enabling the adoption of novel therapies. The Food Allergy Diagnostics and Therapeutics industry is expected to continue growing, driven by increasing demand for effective diagnostic and therapeutic solutions.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Food Allergy Diagnostics and Therapeutics market outlook. The market attractiveness is moderate, driven by increasing prevalence of food allergies and growing demand for diagnostic and therapeutic solutions. The competitive intensity is high, with key players investing heavily in research and development to enhance their market share.

The long-term outlook for the market is promising, with the innovation landscape expected to shift towards more personalized and targeted treatments. However, the demand–supply balance is a key concern, with supply chain disruptions and regulatory hurdles posing significant risks. Other key risk factors include stringent regulatory requirements and high development costs. Overall, the market offers opportunities for growth, but players must navigate these challenges to succeed.

11 items

1. Executive Summary

2. Food Allergy Diagnostics and Therapeutics Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Food Allergy Diagnostics and Therapeutics Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Food Allergy Diagnostics and Therapeutics Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Academic Research Institutes

6.1.2. Hospitals & Clinics

6.1.3. Diagnostics Laboratories

6.2. Global Food Allergy Diagnostics and Therapeutics Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Diagnostic Products

6.2.2. Instruments

6.2.3. Consumables

6.2.4. Services

6.3. Global Food Allergy Diagnostics and Therapeutics Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Food Allergy Diagnostics and Therapeutics Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Food Allergy Diagnostics and Therapeutics Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Food Allergy Diagnostics and Therapeutics Market Competition by Key Manufacturers

8.1. Global Food Allergy Diagnostics and Therapeutics Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Food Allergy Diagnostics and Therapeutics: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Allergy Therapeutics

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cambridge Allergy Ltd

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Astellas Pharma, Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Immunomic Therapeutics, Inc.

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Prota Therapeutics Pty Ltd

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Aimmune Therapeutics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Pfizer

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. ALK-Abello Ltd

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Medeca Pharma AB

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. BioMerieux

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Omega Diagnostics Group

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. HYCOR Biomedical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. HOB Biotech Group

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Food Allergy Diagnostics and Therapeutics Market

Figure 4: Global Food Allergy Diagnostics and Therapeutics Market: Drivers

Figure 5: Global Food Allergy Diagnostics and Therapeutics Market: Challenges

Figure 6: Global Food Allergy Diagnostics and Therapeutics Market: Trends

Figure 7: Global Food Allergy Diagnostics and Therapeutics Market: Opportunity

Figure 8: Global Food Allergy Diagnostics and Therapeutics Market: Restraint

Figure 9: Global Food Allergy Diagnostics and Therapeutics Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Food Allergy Diagnostics and Therapeutics Market Value (USD Million) By Region

Figure 15: Global Food Allergy Diagnostics and Therapeutics Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Food Allergy Diagnostics and Therapeutics Market Value (USD Million) By Region

Figure 23: Global Food Allergy Diagnostics and Therapeutics Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Food Allergy Diagnostics and Therapeutics Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Food Allergy Diagnostics and Therapeutics Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Food Allergy Diagnostics and Therapeutics Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Food Allergy Diagnostics and Therapeutics Market Value (USD Million) By Region

Table 10: Global Food Allergy Diagnostics and Therapeutics Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Food Allergy Diagnostics and Therapeutics Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Food Allergy Diagnostics and Therapeutics Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Food Allergy Diagnostics and Therapeutics Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Allergy Therapeutics Basic Information And Sales Area

Table 31: Allergy Therapeutics. Products Portfolio

Table 32: Cambridge Allergy Ltd Basic Information And Sales Area

Table 33: Cambridge Allergy Ltd. Products Portfolio

Table 34: Astellas Pharma, Inc. Basic Information And Sales Area

Table 35: Astellas Pharma, Inc.. Products Portfolio

Table 36: Immunomic Therapeutics, Inc. Basic Information And Sales Area

Table 37: Immunomic Therapeutics, Inc.. Products Portfolio

Table 38: Prota Therapeutics Pty Ltd Basic Information And Sales Area

Table 39: Prota Therapeutics Pty Ltd. Products Portfolio

Table 40: Aimmune Therapeutics Basic Information And Sales Area

Table 41: Aimmune Therapeutics. Products Portfolio

Table 42: Pfizer Basic Information And Sales Area

Table 43: Pfizer. Products Portfolio

Table 44: ALK-Abello Ltd Basic Information And Sales Area

Table 45: ALK-Abello Ltd. Products Portfolio

Table 46: Medeca Pharma AB Basic Information And Sales Area

Table 47: Medeca Pharma AB. Products Portfolio

Table 48: BioMerieux Basic Information And Sales Area

Table 49: BioMerieux. Products Portfolio

Table 50: Omega Diagnostics Group Basic Information And Sales Area

Table 51: Omega Diagnostics Group. Products Portfolio

Table 52: HYCOR Biomedical Basic Information And Sales Area

Table 53: HYCOR Biomedical. Products Portfolio

Table 54: HOB Biotech Group Basic Information And Sales Area

Table 55: HOB Biotech Group. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Food Allergy Diagnostics and Therapeutics Market Value (USD Million) By Region

Table 61: Global Food Allergy Diagnostics and Therapeutics Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Food Allergy Diagnostics and Therapeutics Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	12.30 billion
Revenue forecast in 2033	23.11 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Allergy Therapeutics; Cambridge Allergy Ltd; Astellas Pharma, Inc.; Immunomic Therapeutics, Inc.; Prota Therapeutics Pty Ltd; Aimmune Therapeutics; Pfizer; ALK-Abello Ltd; Medeca Pharma AB; BioMerieux; Omega Diagnostics Group; HYCOR Biomedical; HOB Biotech Group
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options